13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001974915
申报总市值
US$42.8亿
US$42.8亿
81 檔
11.3%
截至 Q3 2025 季度末，Vestal Point Capital, LP 的美股持仓估值约为 US$42.8亿，全数申报仓位共有 81 档。
在 Q3 2025，Vestal Point Capital, LP 操作展现出积极扩展与加仓意向。本季共新建仓 36 个新仓位，并对 22 个既有持股进行加仓（合计增持 58 档），相较减仓与清仓仓位显著占优。
在资产配置集中度方面，Vestal Point Capital, LP 的前 5 大核心持股（包含 ASND, ACLXGBX, NUVL 等）合计占整体申报市值的 11.3%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ASND | Ascendis Pharma A/S | 股票-其他 | 5.39% | -2.40% | EXIT | |
| 2 | ACLXGBX | Arcellx Inc | 股票-其他 | 4.63% | — | -54.55% | |
| 3 | NUVL | Nuvalent Inc-a | 股票-其他 | 4.30% | -1.38% | EXIT | |
| 4 | ABVX | Abivax Sa-adr | 股票-其他 | 3.83% | +2.65% | — | |
| 5 | ALC | Alcon Inc. | 股票-医疗保健 | 3.70% | -0.91% | +109.52% | |
| 6 | BCAX | Bicara Therapeutics Inc | 股票-其他 | 3.64% | +0.62% | +2.00% | |
| 7 | AM6 | Amicus Therapeutics Inc | 股票-其他 | 3.47% | — | -18.07% | |
| 8 | GMED | Globus Medical Inc - A | 股票-医疗保健 | 3.23% | +0.10% | +150.00% | |
| 9 | IONS | Ionis Pharmaceuticals Inc | 股票-医疗保健 | 3.18% | — | +115.00% | |
| 10 | JAZZ | Jazz Pharmaceuticals plc | 股票-医疗保健 | 2.98% | — | -58.33% | |
| 11 | BDX | Becton Dickinson And Co | 股票-医疗保健 | 2.75% | — | +1200.00% | |
| 12 | SRRK | Scholar Rock Holding CORP | 股票-其他 | 2.52% | -1.82% | EXIT | |
| 13 | ✓ | Immatics NV | 股票-其他 | 2.44% | -0.24% | +1.60% | |
| 14 | RGEN | Repligen CORP | 股票-医疗保健 | 2.41% | -1.77% | — | |
| 15 | DNTH | Dianthus Therapeutics Inc | 股票-其他 | 2.10% | — | -63.13% | |
| 16 | BMRN | Biomarin Pharmaceutical Inc | 股票-医疗保健 | 2.03% | +2.41% | +66.00% | |
| 17 | XENE | Xenon Pharmaceuticals Inc | 股票-其他 | 1.99% | -0.05% | -45.00% | |
| 18 | DXCM | Dexcom Inc | 股票-医疗保健 | 1.98% | — | — | |
| 19 | CYTK | Cytokinetics Inc | 股票-医疗保健 | 1.80% | -0.55% | EXIT | |
| 20 | BIIB | Biogen Inc | 股票-医疗保健 | 1.74% | — | — | |
| 21 | CDTX | Cidara Therapeutics Inc | 股票-其他 | 1.73% | — | -20.00% | |
| 22 | CATBUSD | Astria Therapeutics Inc | 股票-其他 | 1.63% | — | +9.60% | |
| 23 | DYN | Dyne Therapeutics Inc | 股票-其他 | 1.59% | -0.28% | +281.44% | |
| 24 | TYRA | Tyra Biosciences Inc | 股票-其他 | 1.53% | -0.06% | EXIT | |
| 25 | ABT | Abbott Laboratories | 股票-医疗保健 | 1.51% | +2.97% | NEW | |
| 26 | IRON | Disc Medicine Inc | 股票-其他 | 1.49% | +1.40% | +257.14% | |
| 27 | NRIX | Nurix Therapeutics Inc | 股票-其他 | 1.45% | +1.74% | +73.75% | |
| 28 | CRNX | Crinetics Pharmaceuticals In | 股票-其他 | 1.41% | — | -50.00% | |
| 29 | CLDX | Celldex Therapeutics Inc | 股票-其他 | 1.41% | -1.09% | EXIT | |
| 30 | ZYME | Zymeworks Inc | 股票-其他 | 1.36% | — | +53.48% | |
| 31 | DHR | Danaher CORP | 股票-医疗保健 | 1.34% | — | +200.00% | |
| 32 | RVMD | Revolution Medicines Inc | 股票-医疗保健 | 1.33% | -4.49% | -47.50% | |
| 33 | RAPP | Rapport Therapeutics Inc | 股票-其他 | 1.27% | -0.55% | — | |
| 34 | ELVN | Enliven Therapeutics Inc | 股票-其他 | 1.07% | +1.18% | +364.00% | |
| 35 | GERN | Geron CORP | 股票-其他 | 1.07% | -0.11% | EXIT | |
| 36 | BLTE | Belite Bio Inc - Adr | 股票-其他 | 1.04% | — | — | |
| 37 | RARE | Ultragenyx Pharmaceutical In | 股票-其他 | 1.02% | — | — | |
| 38 | VERA | Vera Therapeutics Inc | 股票-其他 | 1.00% | -1.54% | EXIT | |
| 39 | LXEO | Lexeo Therapeutics Inc | 股票-其他 | 0.97% | -0.25% | +0.68% | |
| 40 | BDTX | Black Diamond Therapeutics I | 股票-其他 | 0.95% | — | -0.89% | |
| 41 | DAWNGBX | Day One Biopharmaceuticals I | 股票-其他 | 0.85% | — | -10.83% | |
| 42 | SLDB | Solid Biosciences Inc | 股票-其他 | 0.83% | -0.51% | +97.67% | |
| 43 | AXSM | Axsome Therapeutics Inc | 股票-医疗保健 | 0.82% | — | — | |
| 44 | TSHA | Taysha Gene Therapies Inc | 股票-其他 | 0.81% | +0.84% | +83.33% | |
| 45 | APGE | Apogee Therapeutics Inc | 股票-其他 | 0.76% | -2.59% | EXIT | |
| 46 | SVRA | Savara Inc | 股票-其他 | 0.65% | -0.01% | -63.55% | |
| 47 | BRKR | Bruker CORP | 股票-医疗保健 | 0.65% | — | -12.00% | |
| 48 | REGN | Regeneron Pharmaceuticals | 股票-医疗保健 | 0.63% | -0.28% | — | |
| 49 | QURE | uniQure N.V. | 股票-其他 | 0.59% | +0.85% | -93.92% | |
| 50 | BBNX | Beta Bionics Inc | 股票-其他 | 0.54% | -0.03% | +9.09% |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | ASND | Ascendis Pharma A/S | +3.7% | +200.00% | 加仓 |
| 2 | GMED | Globus Medical Inc - A | +2.2% | +150.00% | 加仓 |
| 3 | CLDX | Celldex Therapeutics Inc | +1.2% | -31.14% | 加仓 |
| 4 | BCAX | Bicara Therapeutics Inc | +1.1% | +2.00% | 加仓 |
| 5 | AM6 | Amicus Therapeutics Inc | +1% | -18.07% | 加仓 |
| 6 | CDTX | Cidara Therapeutics Inc | +1% | -20.00% | 减仓 |
| 7 | ZYME | Zymeworks Inc | +0.9% | +53.48% | 加仓 |
| 8 | LXEO | Lexeo Therapeutics Inc | +0.7% | +0.68% | 加仓 |
| 9 | NRIX | Nurix Therapeutics Inc | +0.5% | +73.75% | 加仓 |
| 10 | SLDB | Solid Biosciences Inc | +0.4% | +97.67% | 加仓 |
| 11 | BDTX | Black Diamond Therapeutics I | +0.3% | -0.89% | 减仓 |
| 12 | DYN | Dyne Therapeutics Inc | +0.3% | +281.44% | 加仓 |
| 13 | VTYXUSD | Ventyx Biosciences Inc | +0.1% | +2.50% | 加仓 |
| 14 | ✓ | Immatics NV | +0.1% | +1.60% | 减仓 |
| 15 | ALEC | Alector Inc | +0.1% | +0.31% | 加仓 |
| 16 | CATBUSD | Astria Therapeutics Inc | 0% | +9.60% | 加仓 |
| 17 | ANRO | Alto Neuroscience Inc | 0% | — | 加仓 |
| 18 | VYGR | Voyager Therapeutics Inc | 0% | — | 加仓 |
| 19 | FATE | Fate Therapeutics Inc | — | — | 减仓 |
| 20 | TENX | Tenax Therapeutics Inc | — | — | 不变 |
| 21 | APLT | Applied Therapeutics Inc | 0% | +23.91% | 加仓 |
| 22 | ✓ | Engene Holdings Inc | 0% | — | 不变 |
| 23 | MGNX | Macrogenics Inc | 0% | — | 不变 |
| 24 | STRO | Sutro Biopharma, Inc. | 0% | — | 不变 |
| 25 | TRAW | Traws Pharma Inc | 0% | +0.13% | 减仓 |
| 26 | DNTH | Dianthus Therapeutics Inc | -0.1% | -63.13% | 减仓 |
| 27 | OKUR | Onkure Therapeutics Inc-a | -0.1% | — | 不变 |
| 28 | BRKR | Bruker CORP | -0.2% | -12.00% | 加仓 |
| 29 | RARE | Ultragenyx Pharmaceutical In | -0.3% | — | 加仓 |
| 30 | TYRA | Tyra Biosciences Inc | -0.4% | -8.66% | 减仓 |
| 31 | SRRK | Scholar Rock Holding CORP | -0.5% | — | 加仓 |
| 32 | DHR | Danaher CORP | -0.5% | +200.00% | 加仓 |
| 33 | DAWNGBX | Day One Biopharmaceuticals I | -0.6% | -10.83% | 加仓 |
| 34 | ✓ | Nyxoah S A | -0.9% | -21.01% | 减仓 |
| 35 | ✓ | Establishment Labs Holdings In | -1.1% | — | 减仓 |
| 36 | XENE | Xenon Pharmaceuticals Inc | -1.1% | -45.00% | 减仓 |
| 37 | NUVL | Nuvalent Inc-a | -1.1% | +2.33% | 加仓 |
| 38 | GERN | Geron CORP | -1.4% | -27.55% | 减仓 |
| 39 | SVRA | Savara Inc | -1.5% | -63.55% | 减仓 |
| 40 | CRNX | Crinetics Pharmaceuticals In | -2.2% | -50.00% | 减仓 |
| 41 | QURE | uniQure N.V. | -3% | -93.92% | 减仓 |
| 42 | VERA | Vera Therapeutics Inc | -3.3% | -75.48% | 减仓 |
| 43 | 4XC1 | Kalvista Pharmaceuticals Inc | -3.5% | -83.96% | 减仓 |
| 44 | CYTK | Cytokinetics Inc | -5.6% | -75.63% | 减仓 |
| 45 | ACLXGBX | Arcellx Inc | -6.6% | -54.55% | 减仓 |
| 46 | ABVX | Abivax Sa-adr | — | NEW | 新建仓 |
| 47 | INSM | Insmed Inc | — | EXIT | 清仓 |
| 48 | ALC | Alcon Inc. | — | NEW | 新建仓 |
| 49 | IONS | Ionis Pharmaceuticals Inc | — | NEW | 新建仓 |
| 50 | JAZZ | Jazz Pharmaceuticals plc | — | NEW | 新建仓 |
根据 SEC 官方 Form 13F 申报备案，Vestal Point Capital, LP 在 Q3 2025 季度的美股持仓总市值约为 US$42.8亿，共申报了 81 个公开持股仓位。
在 Q3 2025 季度，Vestal Point Capital, LP 按市值排列的前三大核心持股分别为：ASND (5.4%)、ACLXGBX (4.6%)、NUVL (4.3%)。其中最大持股仓位 ASND 占据整体投资组合约 5.4% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
ABVX
市值: US$8490.0万
本季最大获利了结 / 清仓标的
INSM
前期市值: US$8201.2万
在 Q3 2025 季度中，Vestal Point Capital, LP 共进行了 94 项持仓异动，包含新建仓 36 个仓位、加仓 22 个仓位、减仓 18 个仓位以及清仓 18 个仓位。 其中最大新建仓标的为 ABVX。 本季清仓仓位包含 INSM。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。